BeOne Medicines Ltd (ONC)

• Market cap: $30.1B
• 1 day: -0.12%
• 5 days: -5.16%
• 1 month: -0.2%
• 3 months: -7.68%
• 6 months: -13.52%
• Year to date: -6.69%
• 1 year: 17.65%
• 5 years: -20.92%
• 10 years: 927.33%
• Sector: Healthcare
• Industry: Biotechnology

About: BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.

Employees: 12,000